Marshall Keith W
Insider CIK 1714828 · CNAT EVP, COO & CFO · RXDX Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RXDX Prometheus Biosciences, In | D To issuer deriv | 2023-06-16 | 2023-06-16 | 52,838 | — | $0 | 0 | SEC↗ |
| RXDX Prometheus Biosciences, In | D To issuer deriv | 2023-06-16 | 2023-06-16 | 93,040 | — | $0 | 0 | SEC↗ |
| RXDX Prometheus Biosciences, In | D To issuer deriv | 2023-06-16 | 2023-06-16 | 135,913 | — | $0 | 0 | SEC↗ |
| RXDX Prometheus Biosciences, In | D To issuer deriv | 2023-06-16 | 2023-06-16 | 102,155 | — | $0 | 0 | SEC↗ |
| RXDX Prometheus Biosciences, In | D To issuer deriv | 2023-06-16 | 2023-06-16 | 86,582 | — | $0 | 0 | SEC↗ |
| RXDX Prometheus Biosciences, In | D To issuer deriv | 2023-06-16 | 2023-06-16 | 12,920 | — | $0 | 0 | SEC↗ |
| RXDX Prometheus Biosciences, In | D To issuer deriv | 2023-06-16 | 2023-06-16 | 34,085 | — | $0 | 0 | SEC↗ |
| RXDX Prometheus Biosciences, In | D To issuer | 2023-06-16 | 2023-06-16 | 87,973 | — | $0 | 0 | SEC↗ |
| RXDX Prometheus Biosciences, In | M Exercise deriv | 2023-06-02 | 2023-06-02 | 78,162 | — | $0 | 52,838 | SEC↗ |
| RXDX Prometheus Biosciences, In | M Exercise | 2023-06-02 | 2023-06-02 | 78,162 | $3.10 | $242.3K | 87,973 | SEC↗ |
| RXDX Prometheus Biosciences, In | M Exercise deriv | 2023-04-05 | 2023-04-07 | 10,000 | — | $0 | 93,040 | SEC↗ |
| RXDX Prometheus Biosciences, In | M Exercise | 2023-04-05 | 2023-04-07 | 10,000 | $3.70 | $37.0K | 19,811 | SEC↗ |
| RXDX Prometheus Biosciences, In | S Sale | 2023-04-05 | 2023-04-07 | 10,000 | $108.42 | $1.08M | 9,811 | SEC↗ |
| RXDX Prometheus Biosciences, In | M Exercise deriv | 2023-03-06 | 2023-03-08 | 10,000 | — | $0 | 103,040 | SEC↗ |
| RXDX Prometheus Biosciences, In | M Exercise | 2023-03-06 | 2023-03-08 | 10,000 | $3.70 | $37.0K | 19,811 | SEC↗ |
| RXDX Prometheus Biosciences, In | S Sale | 2023-03-06 | 2023-03-08 | 10,000 | $122.13 | $1.22M | 9,811 | SEC↗ |
| RXDX Prometheus Biosciences, In | M Exercise deriv | 2023-02-15 | 2023-02-17 | 5,000 | — | $0 | 113,040 | SEC↗ |
| RXDX Prometheus Biosciences, In | S Sale | 2023-02-15 | 2023-02-17 | 5,000 | $119.38 | $596.9K | 9,811 | SEC↗ |
| RXDX Prometheus Biosciences, In | M Exercise | 2023-02-15 | 2023-02-17 | 5,000 | $3.70 | $18.5K | 14,811 | SEC↗ |
| RXDX Prometheus Biosciences, In | M Exercise deriv | 2023-01-17 | 2023-01-19 | 5,000 | — | $0 | 118,040 | SEC↗ |
| RXDX Prometheus Biosciences, In | S Sale | 2023-01-17 | 2023-01-19 | 5,000 | $119.00 | $595.0K | 9,811 | SEC↗ |
| RXDX Prometheus Biosciences, In | M Exercise | 2023-01-17 | 2023-01-19 | 5,000 | $3.70 | $18.5K | 14,811 | SEC↗ |
| RXDX Prometheus Biosciences, In | A Award deriv | 2022-12-16 | 2022-12-20 | 12,920 | — | $0 | 12,920 | SEC↗ |
| RXDX Prometheus Biosciences, In | A Award deriv | 2022-12-09 | 2022-12-13 | 34,085 | — | $0 | 34,085 | SEC↗ |
| RXDX Prometheus Biosciences, In | A Award | 2022-12-09 | 2022-12-13 | 9,811 | — | $0 | 9,811 | SEC↗ |
| RXDX Prometheus Biosciences, In | A Award deriv | 2022-05-20 | 2022-05-20 | 86,582 | — | $0 | 86,582 | SEC↗ |
| RXDX Prometheus Biosciences, In | A Award deriv | 2021-11-14 | 2021-11-16 | 102,155 | — | $0 | 102,155 | SEC↗ |
| HSTO Histogen Inc. | M Exercise deriv | 2020-05-22 | 2020-05-27 | 38,500 | — | $0 | 0 | SEC↗ |
| HSTO Histogen Inc. | M Exercise | 2020-05-22 | 2020-05-27 | 38,500 | — | $0 | 38,500 | SEC↗ |
| HSTO Histogen Inc. | F Tax w/h | 2020-05-22 | 2020-05-27 | 18,615 | $0.56 | $10.4K | 19,885 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | D To issuer deriv | 2019-08-01 | 2019-08-01 | 525,000 | — | $0 | 0 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | D To issuer deriv | 2019-08-01 | 2019-08-01 | 70,000 | — | $0 | 0 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | D To issuer deriv | 2019-08-01 | 2019-08-01 | 175,000 | — | $0 | 0 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2019-08-01 | 2019-08-01 | 385,000 | — | $0 | 385,000 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2019-02-07 | 2019-02-11 | 175,000 | — | $0 | 175,000 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2018-02-04 | 2018-02-05 | 70,000 | — | $0 | 70,000 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2017-08-31 | 2017-09-01 | 525,000 | — | $0 | 525,000 | SEC↗ |